or Try an Advanced Search...

    Cancer Therapies Stocks List

    Symbol Grade Name % Change
    ANL C Adlai Nortye Ltd. 0.00
    SNDX C Syndax Pharmaceuticals, Inc. -2.74
    BYSI C BeyondSpring, Inc. -2.56
    PSNL C Personalis, Inc. -2.22
    KTRA D Kintara Therapeutics, Inc. -4.16
    IOBT D IO Biotech, Inc. -3.90
    APRE D Aprea Therapeutics, Inc. -0.68
    IKNA D Ikena Oncology, Inc. -2.13
    AVBP F ArriVent BioPharma, Inc. 1.10
    RPTX F Repare Therapeutics Inc. 18.29
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Cancer Biopharmaceutical Antineoplastic Drugs Anti Cancer Therapies Biology Biotechnology Cancer Treatment Clinical Medicine Immune System Life Sciences Lung Cancer NSCLC Novel Cancer Pharmaceutical Solid Tumors Tumor Acute Myeloid Leukemia Advanced Non Small Cell Lung Cancer Analysis Services Applied Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Therapies stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 2.1
    ARKG F ARK Genomic Revolution Multi-Sector ETF 1.44
    SBIO C ALPS Medical Breakthroughs ETF 1.2
    XBI D SPDR S&P Biotech ETF 0.98
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 0.88
    View all Cancer Therapies ETFs...
    Compare ETFs
    Compare ARKG to BBC Compare CNCR to BBC Compare CNCR to SBIO

        Cancer Therapies Stocks Recent News

        Date Stock Title
        May 8 AVBP ArriVent BioPharma Reports First Quarter 2024 Financial Results
        May 8 SNDX Syndax Pharmaceuticals GAAP EPS of -$0.85 beats by $0.12
        May 8 SNDX Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
        May 7 RPTX Repare Therapeutics GAAP EPS of $0.30 beats by $0.32, revenue of $52.4M beats by $14M
        May 7 RPTX Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
        May 7 SNDX Syndax Pharmaceuticals Q1 2024 Earnings Preview
        May 3 BYSI BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
        May 2 APRE Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Cancer Biopharmaceutical Antineoplastic Drugs Anti Cancer Therapies Biology Biotechnology Cancer Treatment Clinical Medicine Immune System Life Sciences Lung Cancer NSCLC Novel Cancer Pharmaceutical Solid Tumors Tumor Acute Myeloid Leukemia Advanced Non Small Cell Lung Cancer Analysis Services Applied Genetics
        Cancer Therapies

        Cancer therapies are treatments used to destroy or control cancer cells. These therapies can include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy. Depending on the type and stage of cancer, a combination of therapies may be used.

        Browse All Tags